Cerlapirdine

DB12229InvestigationalSmall molecule

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 6
Curator reviewed
Formula / weight: C₂₂H₂₃N₃O₃S · 409.5 g/mol (avg)
Code names: PF-05212365 · SAM-531 · SAM-531 FREE BASE · WAY-262,531

Resolves to

Compound

Structure

InChIKeyNXQGEDVQXVTCDA-UHFFFAOYSA-NSMILESCN(C)CCCOC1=CC=C2NN=C(C2=C1)S(=O)(=O)C1=C2C=CC=CC2=CC=C1

Targets

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

680Drug interactionsStructured to mechanism, not free text

7Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cerlapirdine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.